Logotype for Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München

Munich RE (MUV2) Q2 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München

Q2 2026 earnings summary

7 Aug, 2026

Executive summary

  • Net result for H1 2026 reached €3,925m, up 23.5% year-over-year, with ROE at 23.0%, driven by strong operating performance, low major-loss expenditure in property-casualty reinsurance, and robust investment returns.

  • Diversified business model with increased contributions from Life Re, Global Specialty Insurance, and ERGO, supporting sustainable earnings and offsetting P&C Reinsurance revenue decline.

  • Digital transformation and branding initiatives at ERGO, including AI and internalization, drive efficiency and profitable growth.

  • Disciplined underwriting led to withdrawal from unprofitable business, especially in P&C Reinsurance, and strategic portfolio optimization.

  • EPS rose 27.3% to €30.89.

Financial highlights

  • H1 2026 net result: €3,925m; Q2 net result: €2,211m; operating result up 14.7% to €5,025m.

  • Investment result for H1 2026: €4,841m, with Q2 return on investment at 5.5% and H1 at 4.2%, supported by strong equity markets.

  • Solvency II ratio at 304% as of Q2 2026; group equity increased to €33.7bn.

  • Combined ratio in property-casualty reinsurance improved to 67.9% (H1), with Q2 at 68.9%; GSI combined ratio: 86.3% (H1), 88.9% (Q2); ERGO Germany: 88.4% (H1).

  • Insurance revenue declined 2.1% to €29,957m, mainly due to currency effects and portfolio pruning.

Outlook and guidance

  • Full-year net result guidance for 2026 maintained at €6.3bn; group insurance revenue guidance revised to €62bn (previously €64bn), and reinsurance revenue to €38bn (previously €40bn).

  • Ambition 2030 targets remain: ROE >18%, EPS growth >8%, payout ratio >80%, Solvency II ratio >200%.

  • Combined ratio targets for property-casualty reinsurance and specialty insurance remain at 80% and 90%, respectively.

  • Guidance subject to uncertainties from geopolitical, macroeconomic, and market developments.

  • ERGO revenue guidance maintained at €24bn, expecting strong H2 growth from internalization, new business, and acquisitions.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more